Company Filing History:
Years Active: 2019
Title: Noa Katz: Innovator in Androgen-Dependent Disorder Treatments
Introduction
Noa Katz is a prominent inventor based in Haifa, Israel. She has made significant contributions to the field of medical treatments, particularly focusing on androgen-dependent disorders. Her innovative work has led to the development of a unique patent that addresses these health issues.
Latest Patents
Noa Katz holds a patent titled "Composition and method for treating androgen-dependent disorders." This patent involves chimeric polypeptides that comprise a dihydrotestosterone (DHT) reductase moiety, such as 3 alpha-hydroxysteroid dehydrogenase (3α-HSD), fused to a signal peptide moiety. The invention also includes polynucleotides encoding the chimeric polypeptide and compositions that contain at least one microorganism cell capable of secreting the chimeric polypeptide. The methods and kits provided by this patent aim to treat, prevent, or ameliorate androgen-dependent disorders, including androgenic alopecia. Noa Katz has 1 patent to her name.
Career Highlights
Noa Katz is associated with the Technion Research & Development Foundation Limited, where she continues to advance her research and innovations. Her work is characterized by a commitment to improving health outcomes for individuals affected by androgen-dependent conditions.
Collaborations
Noa collaborates with talented individuals in her field, including Roee Amit and Alexey Tomsov. These partnerships enhance her research efforts and contribute to the development of effective treatments.
Conclusion
Noa Katz is a dedicated inventor whose work in treating androgen-dependent disorders showcases her innovative spirit and commitment to medical advancements. Her contributions are paving the way for new therapeutic options in this important area of health.